Browse every published article, from the latest research to earlier analysis. Use the page numbers below to explore the complete archive.
A withdrawal meta-analysis’s intubation confidence interval and P value did not support a clear reduction despite inconsistent abstract wording.
A zolpidem case links abrupt cessation after prolonged high-dose exposure with a seizure, while leaving population risk unmeasured.
A K562-cell study of PAP7 and iron transport illustrates the limits of inferring sedative effects from benzodiazepine-related terminology.
In an older-adult ERCP trial, slower induction coexisted with shorter recovery measures under a remimazolam–opioid regimen.
A methodological letter lists perioperative questions relevant to delirium interpretation but supplies no new randomized outcome data.
A supplied retraction notice describes figure concerns in a diazepam–metformin animal paper and changes how its therapeutic claims should be represented.
Changing treatment frequency does not establish that the increasingly used treatment is superior.
An in-vitro interaction signal needs exposure context before it predicts a clinical interaction.
An observational association can reflect why sedation was selected as well as what it did.
Co-detection of a benzodiazepine and an opioid does not identify the mechanism or magnitude of their interaction.
A change in medication exposure does not guarantee a detectable change in every downstream biomarker.
Developmental stage changed the response in this experimental seizure model.
A selective receptor modulator may behave differently across dose and behavioral endpoints.
The comparison changed analgesia while retaining midazolam in every group.
Reported prescribing practices do not establish how carefully each patient was assessed.
A monitor’s displayed index is not a direct reading of a patient’s memory or awareness.
Where participants were recruited helps define how broadly an estimate can be applied.
Giving both groups the same local block helps isolate some anesthetic differences.
Metabolite activity is one part of a recovery assessment.
Procedure-specific subgroup findings should not be flattened into one recovery claim.
The clinical procedure helps determine what successful sedation means.
A favorable overall safety discussion does not establish safety in every vulnerable subgroup.
A patient priority list is evidence about preferences rather than a clinical risk estimate.
A visually distinctive residue is not automatically a validated forensic identification.
Rapid awakening followed active reversal within a monitored anesthetic plan.
An early cellular injury marker and a later functional outcome should not be treated as the same result.
Common monitoring practice and an evidence-based recovery threshold are different claims.
A positive association for one postoperative outcome should not be generalized to all endpoints.
The effect of a multicomponent strategy cannot automatically be assigned to reduced benzodiazepine exposure alone.
The cognitive association occurred in groups that also differed clinically.